The deadline for implementation of the EU Physical Agents (Electromagnetic Field) Directive was originally set as April 2008. As this deadline approached, information about the legislation's likely impact on the daily use of MRI was distributed widely.
Cardiovascular MR imaging has become a valuable diagnostic modality.
Emerging technology gives radiologists an unprecedented view of the brain.
With the advancement of medical imaging technology comes the need for updated safeguards.
Many of the emerging imaging modalities for prostate cancer were first developed for breast cancer patients and then adapted to the prostate. Clearly, almost all aspects of prostate cancer care and diagnosis lag behind those of breast cancer. Breast cancer researchers have successfully carried out a number of groundbreaking randomized controlled trials to define the best treatment approaches, but prostate cancer has yet to see a successful trial comparing even the major forms of prostate cancer treatment: radical prostatectomy and radiation therapy. Adding to the frustration that prostate patients face when no one can tell them the best approach for treating their cancer, two new primary therapies have been sanctioned by the American Urologic Association: cryotherapy and watchful waiting.
PACS are electronic medical image management systems. They consist of image display systems, archiving systems, networks, and interfaces, presenting one unified system to the user. They have been in development since 1982 and have predominantly been used in radiology, transforming manual film operations to a filmless environment. Radiology PACS has evolved from an emerging technology to a mature, billion dollar North American market.
A truism about any rapidly adopted technology, no matter what its specifics, is that the benefits are readily apparent soon after its introduction, and the untoward effects are inevitable but delayed. The initial wave of enthusiasm about a new test or a new technique's virtues drowns out, at least for a while, any discussion about its putative ill effects. This truism is especially apparent when the innovation inspires a metamorphosis in practice and perception that alters the allocation of resources, the focus of training, and the nature of work.
Our vision for the future of CT here at GE Healthcare revolves around one central question. If clinicians struggle to see anatomy or pathology, how can they make a confident diagnosis?
MR imaging has provided important insights into the pathophysiology of multiple sclerosis.1 Conventional MR scans afford only gross estimates of the extent and nature of tissue damage associated with MS,2 however, and the data correlate poorly with measures of concurrent disability in patients. Advances in MRI technology have improved the correlation of its findings with clinical status and increased the utility of MRI data as surrogate markers in monitoring disease progression and response to therapy.3 Newer techniques, such as magnetization transfer (MT), diffusion-weighted, and functional MRI, as well as proton MR spectroscopy and measures of brain and spinal cord atrophy, may help further elucidate MS pathology2 and provide opportunities for new treatment approaches.4
CT perfusion for stroke leaped from clinical discussion forums to the front pages in the last 13 months.
Lack of reimbursement kept PET imaging on a slow track for most of the 1990s. The PET community's efforts to churn out data to persuade the government of the modality's effectiveness began to pay off early in the new century.
The first focused meeting on the use of 3T MR for cardiovascular applications convened under National Institutes of Health sponsorship last September. Luminaries in MR technology and applications met in Washington, DC, for two days under the leadership of National Institute of Biomedical Imaging and Bioengineering director Dr. Roderic Pettigrew.
Complementary methods have helped physicians at M. D. Anderson Cancer Center in Texas improve the success rate of surgical treatments for ectopic parathyroid adenoma.
33-year-old male with history of cyanotic congenital heart disease status post multiple palliative cardiac surgeries.
CHICAGO-Leveraging RSNA and social media can make great things happen in radiology.
Four megatrends affect the way we live and work today. These are globalization, technological advancement, the move from production- to service-based industries, and demographic change. Changes caused by these trends will pose challenges, but these challenges can be managed.
Over the past 15 years, improvements in biopsy needle design, sampling technique, and expertise of radiologists and cytopathologists have developed in concert with imaging technologies to make percutaneous needle biopsy (PNB) the most common interventional radiologic procedure. With skills refined from performing PNB, radiologists can now use a new and promising outgrowth of this technique-percutaneous tumor ablation-to safely and accurately place needles into a variety of malignant lesions to deliver local treatment.
Bone mineral density measurements of the axial and appendicular skeleton are an important part of the diagnosis and follow-up of metabolic bone disease.
Crohn's disease can involve any part of the gastroenteric tract but most often affects the distal ileum and colon. It is characterized by chronic inflammation that extends through all layers of the intestinal wall and involves both mesentery and regional lymph nodes.
A variety of neoplasms, derived from a multitude of tissue types, can develop in the sinonasal tract. Sinonasal neoplasms are classified as epithelial or mesenchymal. Epithelial tumors occur in the epithelial lining of the nasal and sinus cavities, accessory salivary tissue, neuroendocrine tissue, and the olfactory mucosa. Mesenchymal tumors are found in supporting tissues.
Efforts to increase comfort result in speedier exams and improved image quality.
A 39 year-old female with Turner Syndrome completely asymptomatic in the previous years, presented to our department with recent onset of dizziness and fatigue.
MSCT findings and histological feature correlations of pancreatic metastases from clear renal cell carcinoma.
A variety of neoplasms, derived from a multitude of tissue types, can develop in the sinonasal tract. Sinonasal neoplasms are classified as epithelial or mesenchymal. Epithelial tumors occur in the epithelial lining of the nasal and sinus cavities, accessory salivary tissue, neuroendocrine tissue, and the olfactory mucosa. Mesenchymal tumors are found in supporting tissues.
Bone mineral density measurements of the axial and appendicular skeleton are an important part of the diagnosis and follow-up of metabolic bone disease.
Research focused on the causes, diagnosis, treatment, and prevention of cardiovascular disease is progressing rapidly.1 Radiology has always played a central diagnostic role, particularly in the coronary vessels. A technique for selectively catheterizing the coronary arteries was developed in 1959, and conventional x-ray coronary angiography is still considered the gold standard for detecting coronary artery disease.2
Breast MRI has been available for over a decade. It is only now, however, that the examination is becoming recognized as an indispensable adjunct to mammography and ultrasound. Several key factors contribute to this acceptance of clinical breast MRI.
A noninvasive technique to detect vulnerable atherosclerotic plaque is critically needed. Formation of atherosclerotic plaque is a dynamic inflammatory process that involves interactions between atherogenic lipoproteins and macrophages. As vulnerable plaques are usually numerous, extending beyond the culprit plaque and involving multiple vessels, targeting a single plaque underestimates the complexity and extent of disease. Thus, an ideal imaging modality should be able to identify the vulnerable arterial bed and, therefore, the vulnerable patient, to prevent the serious complications of atherosclerosis.